Leptin in non-autoimmune inflammation

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 4, 2009, Pages 285-291

  Cai, Chunlin ^a   Hahn, Bevra H ^a   Matarese, Giuseppe ^b   La Cava, Antonio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CNR   (Italy)

Author keywords

Inflammation; Leptin; Metabolism

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; RECOMBINANT LEPTIN;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BEHCET DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DISEASE SEVERITY; ENDOMETRIOSIS; GLOMERULOSCLEROSIS; HORMONE ACTION; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATORY DISEASE; INNATE IMMUNITY; ISCHEMIC HEART DISEASE; LYMPHOPOIESIS; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; LEPTIN; LIPID METABOLISM; METABOLIC DISEASES; OXIDATIVE STRESS; RECOMBINANT PROTEINS;

EID: 70349551430     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809789352168     Document Type: Review

References (93)

1. Zhang, F.; Basinski, M.B.; Beals, J.M.; Briggs, S.L.; Churgay, L.M.; Clawson, D.K.; DiMarchi, R.D.; Furman, T.C.; Hale, J.E.; Hsiung, H.M.; Schoner, B.E.; Smith, D.P.; Zhang, X.Y.; Wery, J.P.; Schevitz, R.W. Crystal structure of the obese protein leptin-E100. Nature, 1997, 387, 206-9.
2. Friedman, J.M.; Halaas, J.L. Leptin and the regulation of body weight in mammals. Nature, 1998, 395, 763-70.
3. Matarese, G.; La Cava, A. Immune responses in obesity models. Drug Discov. Today: Dis. Mod., 2005, 2, 177-81.
4. Sierra-Honigmann, M.R.; Nath, A.K.; Murakami, C.; García-Cardeña, G.; Papapetropoulos, A.; Sessa, W.C.; Madge, L.A.; Schechner, J.S.; Schwabb, M.B.; Polverini, P.J.; Flores-Riveros, J.R. Biological action of leptin as an angiogenic factor. Science, 1998, 281, 1683-6.
5. Mantzoros, C.S. Role of leptin in reproduction. Ann. N. Y. Acad. Sci., 2000, 900, 174-83.
6. Kalra, S.P. Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches. Nutrition, 2008, 24, 820-6.
7. Goren, I.; Kämpfer, H.; Podda, M.; Pfeilschifter, J.; Frank, S. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes, 2003, 52, 2821-32.
8. Bennett, B.D.; Solar, G.P.; Yuan, J.Q.; Mathias, J.; Thomas, G.R.; Matthews, W. A role for leptin and its cognate receptor in hematopoiesis. Curr. Biol., 1996, 6, 1170-80.
9. Lago, R.; Gómez, R.; Lago, F.; Gómez-Reino, J.; Gualillo, O. Leptin beyond body weight regulation: current concepts concerning its role in immune function and inflammation. Cell. Immunol., 2008, 252, 139-45.
10. La Cava, A.; Matarese, G. The weight of leptin in immunity. Nat. Rev. Immunol., 2004, 4, 371-9.
11. Procaccini, C.; Lourenço, E.V.; Matarese, G.; La Cava, A. Leptin signaling: A key pathway in immune responses. Curr. Signal Transduct. Ther., 2009, 4, 22-30.
12. Kloek, C.; Haq, A.K.; Dunn, S.L.; Lavery, H.J.; Banks, A.S.; Myers, M.G. Jr. Regulation of Jak kinases by intracellular leptin receptor sequences. J. Biol. Chem., 2002, 277, 41547-55.
13. Banks, A.S.; Davis, S.M.; Bates, S.H.; Myers, M.G. Jr. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem., 2000, 275, 14563-72.
14. Hekerman, P.; Zeidler, J.; Bamberg-Lemper, S.; Knobelspies, H.; Lavens, D.; Tavernier, J.; Joost, H.G.; Becker, W. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J., 2005, 272, 109-19.
15. Bjorbaek, C.; El-Haschimi, K.; Frantz, J.D.; Flier, J.S. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem., 1999, 274, 30059-65.
16. Myers, M.G. Jr. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog. Horm. Res., 2004, 59, 287-304.
17. van den Brink, G.R.; O'Toole, T.; Hardwick, J.C.; van den Boogaardt, D.E.; Versteeg, H.H.; van Deventer, S.J.; Peppelenbosch, M.P. Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase. Mol. Cell. Biol. Res. Commun., 2000, 4, 144-50.
18. Bjorbaek, C.; Buchholz, R.M.; Davis, S.M.; Bates, S.H.; Pierroz, D.D.; Gu, H.; Neel, B.G.; Myers, M.G. Jr.; Flier, J.S. Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem., 2001, 276, 4747-4755.
19. Bjorbaek, C.; Uotani, S.; da Silva, B.; Flier, J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem., 1997, 272, 32686-95.
20. Stofega, M.R.; Herrington, J.; Billestrup, N.; Carter-Su, C. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol. Endocrinol., 2000, 14, 1338-50.
21. Lam, Q. L.; Lu, L. Role of leptin in immunity. Cell Mol. Immunol., 2007, 4, 1-13.
22. Takekoshi, K.; Ishii, K.; Nanmoku, T.; Shibuya, S.; Kawakami, Y.; Isobe, K.; Nakai, T. Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Endocrinology, 2001, 142, 4861-71.
23. Flier, J.S. Lowered leptin slims immune response. Nat. Med., 1998, 4, 1124-5.
24. Takeshita, N.; Yoshino, T.; Mutoh, S. Possible involvement of corticosterone in bone loss of genetically diabetic db/db mice. Horm. Metab. Res., 2000, 32, 147-51.
25. Ozata, M.; Ozdemir, I.C.; Licinio, J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab., 1999, 84, 3686-95.
26. Howard, J.K., Lord, G.M.; Matarese, G.; Vendetti, S.; Ghatei, M.A.; Ritter, M.A.; Lechler, R.I.; Bloom, S.R. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest., 1999, 104, 1051-9.
27. Farooqi, I.S.; Matarese, G.; Lord, G.M.; Keogh, J.M.; Lawrence, E.; Agwu, C.; Sanna, V.; Jebb, S.A.; Perna, F.; Fontana, S.; Lechler, R.I.; DePaoli, A.M.; O'Rahilly, S. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest., 2002, 110, 1093-103.
28. Hirose, H.; Saito, I.; Kawai, T.; Nakamura, K.; Maruyama, H.; Saruta, T. Serum leptin level: possible association with haematopoiesis in adolescents, independent of body mass index and serum insulin. Clin. Sci. (Lond)., 1998, 94, 633-6.
29. Wilson, C.A.; Bekele, G.; Nicolson, M.; Ravussin, E.; Pratley, R.E. Relationship of the white blood cell count to body fat: role of leptin. Br. J. Haematol,, 1997, 99, 447-51.
30. Martin-Romero, C.; Santos-Alvarez, J.; Goberna, R.; Sánchez-Margalet, V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell. Immunol., 2000, 199, 15-24.
31. Lord, G.M.; Matarese, G.; Howard, J.K.; Bloom, S.R.; Lechler, R.I. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J. Leukoc. Biol., 2002, 72, 330-8.
32. De Rosa, V.; Procaccini, C.; Calì, G.; Pirozzi, G.; Fontana, S.; Zappacosta, S.; La Cava, A.; Matarese G. A key role of leptin in the control of regulatory T cell proliferation. Immunity, 2007, 26, 241-55.
33. Taleb, S.; Herbin, O.; Ait-Oufella, H.; Verreth, W.; Gourdy, P.; Barateau, V.; Merval, R.; Esposito, B.; Clément, K.; Holvoet, P.; Tedgui, A.; Mallat, Z. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2007, 27, 2691-8.
34. Faggioni, R.; Feingold, K.R.; Grunfeld, C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J., 2001, 15, 2565-71.
35. Otero, M.; Lago, R.; Lago, F.; Casanueva, F.F.; Dieguez, C.; Gómez-Reino, J.J.; Gualillo, O. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett., 2005, 579, 295-301.
36. Sanna, V.; Di Giacomo, A.; La Cava, A.; Lechler, R.I.; Fontana, S.; Zappacosta, S.; Matarese, G. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest., 2003, 111, 241-50.
37. Martin, S.S.; Qasim, A.; Reilly, M.P. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J. Am. Coll. Cardiol., 2008, 52, 1201-10.
38. Beltowski, J. Leptin and atherosclerosis. Atherosclerosis, 2006, 189, 47-60.
39. Yamagishi, S.I.; Edelstein, D.; Du, X.L.; Kaneda, Y.; Guzmán, M.; Brownlee, M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem., 2001, 276, 25096-100.
40. O'Rourke, L., Gronning, L.M.; Yeaman, S.J.; Shepherd, P.R. Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J. Biol. Chem., 2002, 277, 42557-62.
41. Yang, R.; Barouch, L.A. Leptin signaling and obesity: cardiovascular consequences. Circ. Res., 2007, 101, 545-59.
42. Gonzalez-Navarro, H.; Burks, D.J.; Andres, V. Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis. Front. Biosci., 2007, 12, 4439-55
43. Matarese, G.; Mantzoros, C.; La Cava, A. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Curr. Pharm. Des., 2007, 13, 3676-80.
44. Bodary, P.F.; Westrick, R.J.; Wickenheiser, K.J.; Shen, Y.; Eitzman, D.T. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA, 2002, 287, 1706-9.
45. Konstantinides, S.; Schäfer, K.; Koschnick, S.; Loskutoff, D.J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest., 2001, 108, 1533-40.
46. De Mitrio, V.; De Pergola, G.; Vettor, R.; Marino, R.; Sciaraffia, M.; Pagano, C.; Scaraggi, F.A.; Di Lorenzo, L.; Giorgino, R. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. Metabolism, 1999, 48, 960-4.
47. Soderberg, S.; Olsson, T.; Eliasson, M.; Johnson, O.; Ahrén, B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J. Intern. Med., 1999, 245, 533-43.
48. Chu, N.F.; Spiegelman, D.; Hotamisligil, G.S.; Rifai, N.; Stampfer, M.; Rimm, E.B. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis, 2001, 157, 495-503.
49. Guagnano, M.T.; Romano, M.; Falco, A.; Nutini, M.; Marinopiccoli, M.; Manigrasso, M.R.; Basili, S.; Davì, G. Leptin increase is associated with markers of the hemostatic system in obese healthy women. J. Thromb. Haemost. 2003, 1, 2330-4.
50. Taleb, S.; Herbin, O.; Ait-Oufella, H.; Verreth, W.; Gourdy, P.; Barateau, V.; Merval, R.; Esposito, B.; Clément, K.; Holvoet, P.; Tedgui, A.; Mallat, Z. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2007, 27, 2691-8.
51. Pelleymounter, M.A.; Cullen, M.J.; Baker, M.B.; Hecht, R.; Winters, D.; Boone T, Collins, F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 1995, 269, 540-3.
52. Kowalski, T.J.; Liu, S.M.; Leibel, R.L.; Chua, S.C. Jr. Transgenic complementation of leptin-receptor deficiency. I. Rescue of the obesity/ diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene. Diabetes, 2001, 50, 425-35.
53. Covey, S.D.; Wideman, R.D.; McDonald, C.; Unniappan, S.; Huynh, F.; Asadi, A.; Speck, M.; Webber, T.; Chua, S. C.; Kieffer, T.J. The pancreatic β cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab., 2006, 4, 291-302.
54. Kieffer, T.J.; Habener, J.F. The adipoinsular axis: effects of leptin on pancreatic β-cells. Am. J. Physiol. Endocrinol. Metab., 2000, 278, E1-14.
55. Seufert, J.; Kieffer, T.J.; Habener, J.F. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc. Natl. Acad. Sci. USA, 1999, 96, 674-9.
56. + channels in pancreatic β-cells. Diabetes, 1997, 46, 1087-93.
57. Fehmann, H.C.; Bode, H.P.; Ebert, T.; Karl, A.; Göke, B. Interaction of GLP-I and leptin at rat pancreatic β-cells: effects on insulin secretion and signal transduction. Horm. Metab. Res., 1997, 29, 572-6.
58. Wabitsch, M.; Blum, W.F.; Muche, R.; Braun, M.; Hube, F.; Rascher, W.; Heinze, E.; Teller, W.; Hauner, H. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J. Clin. Invest., 1997, 100, 808-13.
59. Zhao, A.Z.; Bornfeldt, K.E.; Beavo, J.A. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J. Clin. Invest., 1998, 102, 869-73.
60. Kamohara, S.; Burcelin, R.; Halaas, J.L.; Friedman, J.M.; Charron, M.J. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature, 1997, 389, 374-7.
61. Wang, J.L.; Chinookoswong, N.; Scully, S.; Qi, M.; Shi, Z.Q. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology, 1999, 140, 2117-24.
62. Rossetti, L.; Massillon, D.; Barzilai, N.; Vuguin, P.; Chen, W.; Hawkins, M.; Wu, J.; Wang, J. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J. Biol. Chem., 1997, 272, 27758-63.
63. Lee, Y.; Wang, M.Y.; Kakuma, T.; Wang, Z.W.; Babcock, E.; McCorkle, K.; Higa, M.; Zhou, Y.T.; Unger, R.H. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem., 2001, 276, 5629-35.
64. Licinio, J.; Caglayan, S.; Ozata, M.; Yildiz, B.O.; de Miranda, P.B.; O'Kirwan, F.; Whitby, R.; Liang, L.; Cohen, P.; Bhasin, S.; Krauss, R.M.; Veldhuis, J.D.; Wagner, A.J.; DePaoli, A.M.; McCann, S.M.; Wong, M.L. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc. Natl. Acad. Sci. USA, 2004, 101, 4531-6.
65. Franks, P.W.; Brage, S.; Luan, J.; Ekelund, U.; Rahman, M.; Farooqi, I.S.; Halsall, I.; O'Rahilly, S.; Wareham, N.J. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes. Res., 2005, 13, 1476-84.
66. Yu, X.; Park, B.H.; Wang, M.Y.; Wang, Z.V.; Unger, R.H. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc. Natl. Acad. Sci. USA, 2008, 105, 14070-5.
67. Cumin, F.; Baum, H.P.; Levens, N. Leptin is cleared from the circulation primarily by the kidney. Int. J. Obes. Relat. Metab. Disord., 1996, 20, 1120-1126.
68. Serradeil-Le Gal, C.; Raufaste, D.; Brossard, G.; Pouzet, B.; Marty, E.; Maffrand, J.P.; Le Fur, G. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett., 1997, 404, 185-91.
69. Wolf, G.; Ziyadeh, F.N. Leptin and renal fibrosis. Contrib. Nephrol., 2006, 151, 175-83.
70. Wolf, G.; Hamann, A.; Han, D.C.; Helmchen, U.; Thaiss, F.; Ziyadeh, F.N.; Stahl, R.A. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int., 1999, 56, 860-72.
71. Tarzi, R.M.; Cook, H.T.; Jackson, I.; Pusey, C.D.; Lord, G.M. Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am. J. Pathol., 2004, 164, 385-90.
72. Fruehwald-Schultes, B.; Kern, W.; Beyer, J.; Forst, T.; Pfützner, A.; Peters, A. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria. Metabolism, 1999, 48, 1290-3.
73. Wilson, C.; Nelson, R.; Nicolson, M.; Pratley, R. Plasma leptin concentrations: no difference between diabetic Pima Indians with and without nephropathy. Diabetologia, 1998, 41, 861-2.
74. Sheth, S.G.; Gordon, F.D.; Chopra, S. Nonalcoholic steatohepatitis. Ann. Intern. Med., 1997, 126, 137-45.
75. Chitturi, S.; Farrell, G.; Frost, L.; Kriketos, A.; Lin, R.; Fung, C.; Liddle, C.; Samarasinghe, D.; George, J. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology, 2002, 36, 403-9.
76. Nakamuta, M.; Tada, S.; Uchimura, K.; Enjoji, M.; Kinukawa, N.; Iwamoto, H.; Sugimoto, R.; Shimada, M.; Ohashi, M.; Sugimachi, K.; Nawata, H. Serum leptin levels in patients with nonalcoholic chronic liver disease. Hepatogastroenterology, 2001, 48, 527-32.
77. Tsochatzis, E.; Papatheodoridis, G.V.; Archimandritis, A.J. The evolving role of leptin and adiponectin in chronic liver diseases. Am. J. Gastroenterol., 2006, 101, 2629-40.
78. Kamada, Y.; Takehara, T.; Hayashi, N. Adipocytokines and liver disease. J. Gastroenterol., 2008, 43, 811-22.
79. Celli, B.R.; MacNee, W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J., 2004, 23, 932-46.
80. Broekhuizen, R.; Vernooy, J.H.; Schols, A.M.; Dentener, M.A.; Wouters, E.F. Leptin as local inflammatory marker in COPD. Respir. Med., 2005, 99, 70-4.
81. Wouters, E.F.; Groenewegen, K.H.; Dentener, M.A.; Vernooy, J.H. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc. Am. Thorac. Soc., 2007, 4, 626-34.
82. Evereklioglu, C.; Inalöz, H.S.; Kirtak, N.; Doganay, S.; Bülbül, M.; Ozerol, E.; Er, H.; Ozbek, E. Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activity. Br. J. Dermatol., 2002, 147, 331-6.
83. Kavuncu, S.; Koç, F.; Kurt, M.; Eryüksel, B.; Ortaç, S.; Ozdal, P.; Firat, E. Evaluation of serum leptin concentration in Behcet's disease with ocular involvement. Graefes Arch. Clin. Exp. Ophthalmol., 2005, 243, 1158-60.
84. Yalcindag, F.N.; Kisa, U.; Batioǧlu, F.; Yalçindaǧ, A.; Ozdemir, O.; Caǧlayan, O. Serum leptin levels in patients with ocular and nonocular Behcet's disease. Mediat. Inflamm., 2007, 31986.
85. Giudice, L.C.; Kao, L.C. Endometriosis. Lancet, 2004, 364, 1789-99.
86. Matarese, G.; Alviggi, C.; Sanna, V.; Howard, J.K.; Lord, G.M.; Carravetta, C.; Fontana, S.; Lechler, R.I.; Bloom, S.R.; De Placido, G. Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J. Clin. Endocrinol. Metab., 2000, 85, 2483-7.
87. Bedaiwy, M.A.; Falcone, T.; Goldberg, J.M.; Sharma, R.K.; Nelson, D.R.; Agarwal, A. Peritoneal fluid leptin is associated with chronic pelvic pain but not infertility in endometriosis patients. Hum. Reprod., 2006, 21, 788-91.
88. De Placido, G.; Alviggi, C.; Carravetta, C.; Pisaturo, M.L.; Sanna, V.; Wilding, M.; Lord, G.M.; Matarese, G. The peritoneal fluid concentration of leptin is increased in women with peritoneal but not ovarian endometriosis. Hum. Reprod., 2001, 16, 1251-4.
89. Mahutte, N.G.; Matalliotakis, I.M.; Goumenou, A.G.; Vassiliadis, S.; Koumantakis, G.E.; Arici, A. Inverse correlation between peritoneal fluid leptin concentrations and the extent of endometriosis. Hum. Reprod., 2003, 18, 1205-9.
90. Viganò, P.; Somigliana, E.; Matrone, R.; Dubini, A.; Barron, C.; Vignali, M.; di Blasio, A.M. Serum leptin concentrations in endometriosis. J. Clin. Endocrinol. Metab., 2002, 87, 1085-7.
91. Wertel, I.; Gogacz, M.; Polak, G.; Jakowicki, J.; Kotarski, J. Leptin is not involved in the pathophysiology of endometriosis-related infertility. Eur. J. Obstet. Gynecol. Reprod. Biol., 2005, 119, 206-9.
92. Agrawal, A.; Lourenço, E.V.; Gupta, S.; La Cava, A. Gender-based differences in leptinemia in healthy aging, non-obese individuals associate with increased marker of oxidative stress. Int. J. Clin. Exp. Med., 2008, 1, 305-9.
93. Brennan, A.M.; Lee, J.H.; Tsiodras, S.; Chan, J.L.; Doweiko, J.; Chimienti, S.N.; Wadhwa, S.G.; Karchmer, A.W.; Mantzoros, C.S. r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans. Eur. J. Endocrinol., 2009, 160, 173-6.